bepridil has been researched along with Muscular Dystrophy, Animal in 2 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Muscular Dystrophy, Animal: MUSCULAR DYSTROPHY that occurs in VERTEBRATE animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kerr, LM | 1 |
| Sperelakis, N | 1 |
| Lucas-Heron, B | 1 |
| Loirat, MJ | 1 |
| Ollivier, B | 1 |
| Leoty, C | 1 |
2 other studies available for bepridil and Muscular Dystrophy, Animal
| Article | Year |
|---|---|
Ca2+-dependent slow action potentials in normal and dystrophic mouse skeletal muscle.
Topics: Action Potentials; Animals; Bepridil; Calcium; Glycerol; Kinetics; Lanthanum; Manganese; Mice; Mice, | 1983 |
Calcium-related defects in cardiac and skeletal muscles of dystrophic mice.
Topics: Animals; Anti-Arrhythmia Agents; Bepridil; Calcium; Calcium-Binding Proteins; Calcium-Transporting A | 1987 |